We could not find any results for:
Make sure your spelling is correct or try broadening your search.
DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hyperten... DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Show more
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution PR Newswire NEW YORK, April 18, 2024 Dario selected to provide integrated and proven solutions to improve...
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health PR Newswire NEW YORK, April 10, 2024 Studies include a Randomized Controlled Trial demonstrating...
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health PR Newswire NEW YORK, April 2, 2024 Dario selected to provide integrated approach to improve...
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results PR Newswire NEW YORK, March 28, 2024 Full-year 2023 revenue of $20.4 million reflects a decrease from 2022...
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH PR Newswire NEW YORK, March 21, 2024 Company to host conference call and webcast atΒ 8:30am ET NEW YORK, March 21, 2024...
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications PR...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.26 | -18.0555555556 | 1.44 | 1.44 | 1.0501 | 112855 | 1.1844129 | CS |
4 | -0.29 | -19.7278911565 | 1.47 | 1.66 | 1.0501 | 133564 | 1.36873164 | CS |
12 | -0.9 | -43.2692307692 | 2.08 | 2.6 | 1.0501 | 133806 | 1.76275533 | CS |
26 | -1.58 | -57.2463768116 | 2.76 | 2.83 | 0.68 | 169133 | 1.60639991 | CS |
52 | -2.26 | -65.6976744186 | 3.44 | 4.58 | 0.68 | 141491 | 2.3566232 | CS |
156 | -17.07 | -93.5342465753 | 18.25 | 23.7999 | 0.68 | 181572 | 7.88587696 | CS |
260 | 0.44 | 59.4594594595 | 0.74 | 31.85 | 0.2 | 166237 | 9.37058848 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions